Getagraph.com logo
S&P 500
(1.19%) 5 108.47 points
Dow Jones
(0.55%) 38 296 points
Nasdaq
(2.17%) 15 951 points
Oil
(0.41%) $83.91
Gas
(-4.58%) $1.563
Gold
(0.16%) $2 346.30
Silver
(-0.43%) $27.24
Platinum
(0.16%) $922.00
USD/EUR
(0.35%) $0.935
USD/NOK
(0.70%) $11.03
USD/GBP
(0.18%) $0.801
USD/RUB
(-0.32%) $91.87

Realtime updates for Jiangsu Hengrui Medicine [600276.SS]

Exchange: SHH Sector: Healthcare Industry: Drug Manufacturersā€”General
Last Updated26 Apr 2024 @ 03:00
25% discount on Stockinvest.us - Use code: Podcast

2.96% CNY 45.61

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 03:00):

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications...

Stats
Today's Volume 34.28M
Average Volume 29.96M
Market Cap 289.72B
EPS CNY0.210 ( 2024-04-25 )
Last Dividend CNY0 ( N/A )
Next Dividend CNY0 ( N/A )
P/E 65.16
ATR14 CNY0.0310 (0.07%)

Volume Correlation

Long: 0.29 (neutral)
Short: 0.02 (neutral)
Signal:(43.288) Neutral

Jiangsu Hengrui Medicine Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jiangsu Hengrui Medicine Correlation - Currency/Commodity

The country flag 0.24
( neutral )
The country flag 0.09
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.15
( neutral )
The country flag 0.13
( neutral )

Jiangsu Hengrui Medicine Financials

Annual 2023
Revenue: CNY22.82B
Gross Profit: CNY19.29B (84.55 %)
EPS: CNY0.680
FY 2023
Revenue: CNY22.82B
Gross Profit: CNY19.29B (84.55 %)
EPS: CNY0.680
FY 2022
Revenue: CNY21.28B
Gross Profit: CNY17.79B (83.61 %)
EPS: CNY0.610
FY 2021
Revenue: CNY25.91B
Gross Profit: CNY22.16B (85.56 %)
EPS: CNY0.710

Financial Reports:

No articles found.

Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators